Actin cytoskeletal mediators of motility and invasion amplified and overexpressed in head and neck cancer

详细信息    查看全文

• 作者：Laura C. Kelley (1)
  Sohrab Shahab (2)
  Scott A. Weed (1)
  
• 关键词：Actin ; Gene amplification ; Head and neck squamous cell carcinoma ; Invasion ; Metastasis ; Motility
• 刊名：Clinical & Experimental Metastasis
• 出版年：2008
• 出版时间：June 2008
• 年：2008
• 卷：25
• 期：4
• 页码：289-304
• 全文大小：329KB
• 参考文献：1. Kramer RH, Shen X, Zhou H (2005) Tumor cell invasion and survival in head and neck cancer. Cancer Metastasis Rev 24(1):35鈥?5 CrossRef
  2. Howell GM, Grandis JR (2005) Molecular mediators of metastasis in head and neck squamous cell carcinoma. Head Neck 27(8):710鈥?17 CrossRef
  3. Braakhuis BJ, Senft A, de Bree R et al (2006) Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol 59(12):1254鈥?260 CrossRef
  4. Ginos MA, Page GP, Michalowicz BS et al (2004) Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 64(1):55鈥?3 CrossRef
  5. Chung CH, Parker JS, Karaca G et al (2004) Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5(5):489鈥?00 CrossRef
  6. Yamazaki D, Kurisu S, Takenawa T (2005) Regulation of cancer cell motility through actin reorganization. Cancer Sci 96(7):379鈥?86 CrossRef
  7. Yamaguchi H, Condeelis J (2006) Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 1773(5):642鈥?52
  8. Ridley AJ, Schwartz MA, Burridge K et al (2003) Cell migration: integrating signals from front to back. Science 302(5651):1704鈥?709 CrossRef
  9. Yamaguchi H, Wyckoff J, Condeelis J (2005) Cell migration in tumors. Curr Opin Cell Biol 17(5):559鈥?64 CrossRef
  10. Wells A (2000) Tumor invasion: role of growth factor-induced cell motility. Adv Cancer Res 78:31鈥?01 CrossRef
  11. Avizienyte E, Frame MC (2005) Src and FAK signalling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr Opin Cell Biol 17(5):542鈥?47 CrossRef
  12. Guo W, Giancotti FG (2004) Integrin signalling during tumour progression. Nat Rev Mol Cell Biol 5(10):816鈥?26 CrossRef
  13. Frame MC, Brunton VG (2002) Advances in Rho-dependent actin regulation and oncogenic transformation. Curr Opin Genet Dev 12(1):36鈥?3 CrossRef
  14. Pollard TD, Borisy GG (2003) Cellular motility driven by assembly and disassembly of actin filaments. Cell 112(4):453鈥?65 CrossRef
  15. Friedl P, Brocker EB (2000) The biology of cell locomotion within three-dimensional extracellular matrix. Cell Mol Life Sci 57(1):41鈥?4 CrossRef
  16. Sahai E (2005) Mechanisms of cancer cell invasion. Curr Opin Genet Dev 15(1):87鈥?6 CrossRef
  17. Condeelis J, Singer RH, Segall JE (2005) The great escape: when cancer cells hijack the genes for chemotaxis and motility. Annu Rev Cell Dev Biol 21:695鈥?18 CrossRef
  18. Gollin SM (2001) Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23(3):238鈥?53 CrossRef
  19. Bockmuhl U, Schluns K, Schmidt S, Matthias S, Petersen I (2002) Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer 33(1):29鈥?5 CrossRef
  20. Patmore HS, Cawkwell L, Stafford ND, Greenman J (2005) Unraveling the chromosomal aberrations of head and neck squamous cell carcinoma: a review. Ann Surg Oncol 12(10):831鈥?42 CrossRef
  21. Lin M, Smith LT, Smiraglia DJ et al (2006) DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25(9):1424鈥?433 CrossRef
  22. Ashburner M, Ball CA, Blake JA et al (2000) Gene ontology: tool for the unification of biology. The Gene Ontology Consortium Nat Genet 25(1):25鈥?9 CrossRef
  23. Singh B, Gogineni SK, Sacks PG et al (2001) Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 61(11):4506鈥?513
  24. Singh B, Stoffel A, Gogineni S et al (2002) Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 161(2):365鈥?71
  25. Slebos RJ, Yi Y, Ely K et al (2006) Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12(3 Pt 1):701鈥?09 CrossRef
  26. Blobe GC, Stribling S, Obeid LM, Hannun YA (1996) Protein kinase C isoenzymes: regulation and function. Cancer Surv 27:213鈥?48
  27. Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332( Pt 2):281鈥?92
  28. Xu L, Deng X (2006) Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and m-calpains. J Biol Chem 281(7):4457鈥?466 CrossRef
  29. Regala RP, Weems C, Jamieson L et al (2005) Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 65(19):8905鈥?911 CrossRef
  30. Zhang L, Huang J, Yang N et al (2006) Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res 66(9):4627鈥?635 CrossRef
  31. Weichert W, Gekeler V, Denkert C, Dietel M, Hauptmann S (2003) Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis. Int J Oncol 23(3):633鈥?39
  32. Steed PM, Chow AH (2001) Intracellular signaling by phospholipase D as a therapeutic target. Curr Pharm Biotechnol 2(3):241鈥?56 CrossRef
  33. Jenkins GM, Frohman MA (2005) Phospholipase D: a lipid centric review. Cell Mol Life Sci 62(19鈥?0):2305鈥?316 CrossRef
  34. Kim JH, Kim HW, Jeon H, Suh PG, Ryu SH (2006) Phospholipase D1 regulates cell migration in a lipase activity-independent manner. J Biol Chem 281(23):15747鈥?5756 CrossRef
  35. Ahn BH, Kim SY, Kim EH et al (2003) Transmodulation between phospholipase D and c-Src enhances cell proliferation. Mol Cell Biol 23(9):3103鈥?115 CrossRef
  36. Noh DY, Ahn SJ, Lee RA et al (2000) Overexpression of phospholipase D1 in human breast cancer tissues. Cancer Lett 161(2):207鈥?14 CrossRef
  37. Zheng Y, Rodrik V, Toschi A et al (2006) Phospholipase D couples survival and migration signals in stress response of human cancer cells. J Biol Chem 281(23):15862鈥?5868 CrossRef
  38. Fresno Vara JA, Casado E, de Castro J, Cejas P, Belda-Iniesta C, Gonzalez-Baron M (2004) PI3K/Akt signalling pathway and cancer. Cancer Treat Rev 30(2):193鈥?04 CrossRef
  39. Cantrell DA (2001) Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114(Pt 8):1439鈥?445
  40. Volinia S, Hiles I, Ormondroyd E et al (1994) Molecular cloning, cDNA sequence, and chromosomal localization of the human phosphatidylinositol 3-kinase p110 alpha (PIK3CA) gene. Genomics 24(3):472鈥?77 CrossRef
  41. Estilo CL, O-Charoenrat P, Ngai I et al (2003) The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110alpha in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9(6):2300鈥?306
  42. Roymans D, Slegers H (2001) Phosphatidylinositol 3-kinases in tumor progression. Eur J Biochem 268(3):487鈥?98 CrossRef
  43. Hill K, Welti S, Yu J et al (2000) Specific requirement for the p85-p110alpha phosphatidylinositol 3-kinase during epidermal growth factor-stimulated actin nucleation in breast cancer cells. J Biol Chem 275(6):3741鈥?744 CrossRef
  44. Tan M, Grijalva R, Yu D (1999) Heregulin beta1-activated phosphatidylinositol 3-kinase enhances aggregation of MCF-7 breast cancer cells independent of extracellular signal-regulated kinase. Cancer Res 59(7):1620鈥?625
  45. Woenckhaus J, Steger K, Werner E et al (2002) Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma. J Pathol 198(3):335鈥?42 CrossRef
  46. Tsukita S, Furuse M (2000) Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149(1):13鈥?6 CrossRef
  47. Hewitt KJ, Agarwal R, Morin PJ (2006) The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6:186 CrossRef
  48. Resnick MB, Konkin T, Routhier J, Sabo E, Pricolo VE (2005) Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18(4):511鈥?18 CrossRef
  49. Morin PJ (2005) Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65(21):9603鈥?606 CrossRef
  50. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T (2006) Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 66(10):5251鈥?257 CrossRef
  51. Thelemann A, Petti F, Griffin G et al (2005) Phosphotyrosine signaling networks in epidermal growth factor receptor overexpressing squamous carcinoma cells. Mol Cell Proteomics 4(4):356鈥?76 CrossRef
  52. van der Horst EH, Degenhardt YY, Strelow A et al (2005) Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1. Proc Natl Acad Sci U S A 102(44):15901鈥?5906 CrossRef
  53. Manser E, Leung T, Salihuddin H, Tan L, Lim L (1993) A non-receptor tyrosine kinase that inhibits the GTPase activity of p21cdc42. Nature 363(6427):364鈥?67 CrossRef
  54. Kato J, Kaziro Y, Satoh T (2000) Activation of the guanine nucleotide exchange factor Dbl following ACK1-dependent tyrosine phosphorylation. Biochem Biophys Res Commun 268(1):141鈥?47 CrossRef
  55. Eisenmann KM, McCarthy JB, Simpson MA et al (1999) Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat Cell Biol 1(8):507鈥?13 CrossRef
  56. Chodniewicz D, Klemke RL (2004) Regulation of integrin-mediated cellular responses through assembly of a CAS/Crk scaffold. Biochim Biophys Acta 1692(2鈥?):63鈥?6
  57. Yokoyama N, Lougheed J, Miller WT (2005) Phosphorylation of WASP by the Cdc42-associated kinase ACK1: dual hydroxyamino acid specificity in a tyrosine kinase. J Biol Chem 280(51):42219鈥?2226 CrossRef
  58. Galisteo ML, Yang Y, Urena J, Schlessinger J (2006) Activation of the nonreceptor protein tyrosine kinase Ack by multiple extracellular stimuli. Proc Natl Acad Sci U S A 103(26):9796鈥?801 CrossRef
  59. Satoh T, Kato J, Nishida K, Kaziro Y (1996) Tyrosine phosphorylation of ACK in response to temperature shift-down, hyperosmotic shock, and epidermal growth factor stimulation. FEBS Lett 386(2鈥?):230鈥?34 CrossRef
  60. Mahajan NP, Whang YE, Mohler JL, Earp HS (2005) Activated tyrosine kinase Ack1 promotes prostate tumorigenesis: role of Ack1 in polyubiquitination of tumor suppressor Wwox. Cancer Res 65(22):10514鈥?0523 CrossRef
  61. Huang Q, Yu GP, McCormick SA et al (2002) Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34(2):224鈥?33 CrossRef
  62. Bockmuhl U, Schwendel A, Dietel M, Petersen I (1996) Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res 56(23):5325鈥?329
  63. Squire JA, Bayani J, Luk C et al (2002) Molecular cytogenetic analysis of head and neck squamous cell carcinoma: by comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 24(9):874鈥?87 CrossRef
  64. Stracke ML, Clair T, Liotta LA (1997) Autotaxin, tumor motility-stimulating exophosphodiesterase. Adv Enzyme Regul 37:135鈥?44 CrossRef
  65. Nam SW, Clair T, Campo CK, Lee HY, Liotta LA, Stracke ML (2000) Autotaxin (ATX), a potent tumor motogen, augments invasive and metastatic potential of ras-transformed cells. Oncogene 19(2):241鈥?47 CrossRef
  66. Clair T, Lee HY, Liotta LA, Stracke ML (1997) Autotaxin is an exoenzyme possessing 5鈥?nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities. J Biol Chem 272(2):996鈥?001 CrossRef
  67. Lee HY, Clair T, Mulvaney PT et al (1996) Stimulation of tumor cell motility linked to phosphodiesterase catalytic site of autotaxin. J Biol Chem 271(40):24408鈥?4412 CrossRef
  68. Umezu-Goto M, Kishi Y, Taira A et al (2002) Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158(2):227鈥?33 CrossRef
  69. Hama K, Aoki J, Fukaya M et al (2004) Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1. J Biol Chem 279(17):17634鈥?7639 CrossRef
  70. Nam SW, Clair T, Kim YS et al (2001) Autotaxin (NPP-2), a metastasis-enhancing motogen, is an angiogenic factor. Cancer Res 61(18):6938鈥?944
  71. Yang Y, Mou L, Liu N, Tsao MS (1999) Autotaxin expression in non-small-cell lung cancer. Am J Respir Cell Mol Biol 21(2):216鈥?22
  72. Yang SY, Lee J, Park CG et al (2002) Expression of autotaxin (NPP-2) is closely linked to invasiveness of breast cancer cells. Clin Exp Metastasis 19(7):603鈥?08 CrossRef
  73. Lee YG, Macoska JA, Korenchuk S, Pienta KJ (2002) MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4(4):291鈥?94 CrossRef
  74. Machesky LM, Johnston SA (2007) MIM: a multifunctional scaffold protein. J Mol Med 85(6):569鈥?76 CrossRef
  75. Bompard G, Sharp SJ, Freiss G, Machesky LM (2005) Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B. J Cell Sci 118(Pt 22):5393鈥?403 CrossRef
  76. Lin J, Liu J, Wang Y et al (2005) Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 24(12):2059鈥?066 CrossRef
  77. Wang Y, Zhou K, Zeng X, Lin J, Zhan X (2007) Tyrosine phosphorylation of missing in metastasis protein is implicated in platelet-derived growth factor-mediated cell shape changes. J Biol Chem 282(10):7624鈥?631 CrossRef
  78. Loberg RD, Neeley CK, Adam-Day LL et al (2005) Differential expression analysis of MIM (MTSS1) splice variants and a functional role of MIM in prostate cancer cell biology. Int J Oncol 26(6):1699鈥?705
  79. Nixdorf S, Grimm MO, Loberg R et al (2004) Expression and regulation of MIM (Missing In Metastasis), a novel putative metastasis suppressor gene, and MIM-B, in bladder cancer cell lines. Cancer Lett 215(2):209鈥?20 CrossRef
  80. Utikal J, Gratchev A, Muller-Molinet I et al (2006) The expression of metastasis suppressor MIM/MTSS1 is regulated by DNA methylation. Int J Cancer 119(10):2287鈥?293 CrossRef
  81. Schlaepfer DD, Mitra SK (2004) Multiple connections link FAK to cell motility and invasion. Curr Opin Genet Dev 14(1):92鈥?01 CrossRef
  82. McLean GW, Carragher NO, Avizienyte E, Evans J, Brunton VG, Frame MC (2005) The role of focal-adhesion kinase in cancer - a new therapeutic opportunity. Nat Rev Cancer 5(7):505鈥?15 CrossRef
  83. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, Parsons JT (1992) pp125FAK a structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci U S A 89(11):5192鈥?196 CrossRef
  84. Kanner SB, Reynolds AB, Vines RR, Parsons JT (1990) Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci U S A 87(9):3328鈥?332 CrossRef
  85. Ilic D, Furuta Y, Kanazawa S et al (1995) Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 377(6549):539鈥?44 CrossRef
  86. Hsia DA, Mitra SK, Hauck CR et al (2003) Differential regulation of cell motility and invasion by FAK. J Cell Biol 160(5):753鈥?67 CrossRef
  87. Gabarra-Niecko V, Schaller MD, Dunty JM (2003) FAK regulates biological processes important for the pathogenesis of cancer. Cancer Metastasis Rev 22(4):359鈥?74 CrossRef
  88. Canel M, Secades P, Rodrigo JP et al (2006) Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number. Clin Cancer Res 12(11 Pt 1):3272鈥?279 CrossRef
  89. Johnson FM, Saigal B, Talpaz M, Donato NJ (2005) Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells. Clin Cancer Res 11(19 Pt 1):6924鈥?932 CrossRef
  90. van Nimwegen MJ, van de Water B (2007) Focal adhesion kinase: a potential target in cancer therapy. Biochem Pharmacol 73(5):597鈥?09 CrossRef
  91. Shi Q, Hjelmeland AB, Keir ST et al (2007) A novel low-molecular weight inhibitor of focal adhesion kinase, TAE226, inhibits glioma growth. Mol Carcinog 46(6):488鈥?96 CrossRef
  92. Slack-Davis JK, Martin KH, Tilghman RW et al (2007) Cellular characterization of a novel focal adhesion kinase inhibitor. J Biol Chem 282(20):14845鈥?4852 CrossRef
  93. Randazzo PA, Andrade J, Miura K et al (2000) The Arf GTPase-activating protein ASAP1 regulates the actin cytoskeleton. Proc Natl Acad Sci U S A 97(8):4011鈥?016 CrossRef
  94. Sabe H, Onodera Y, Mazaki Y, Hashimoto S (2006) ArfGAP family proteins in cell adhesion, migration and tumor invasion. Curr Opin Cell Biol 18(5):558鈥?64 CrossRef
  95. Randazzo PA, Hirsch DS (2004) Arf GAPs: multifunctional proteins that regulate membrane traffic and actin remodelling. Cell Signal 16(4):401鈥?13 CrossRef
  96. Kam JL, Miura K, Jackson TR et al (2000) Phosphoinositide-dependent activation of the ADP-ribosylation factor GTPase-activating protein ASAP1. Evidence for the pleckstrin homology domain functioning as an allosteric site. J Biol Chem 275(13):9653鈥?663 CrossRef
  97. Brown MT, Andrade J, Radhakrishna H, Donaldson JG, Cooper JA, Randazzo PA (1998) ASAP1, a phospholipid-dependent arf GTPase-activating protein that associates with and is phosphorylated by Src. Mol Cell Biol 18(12):7038鈥?051
  98. D鈥橲ouza-Schorey C, Chavrier P (2006) ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7(5):347鈥?58 CrossRef
  99. Liu Y, Loijens JC, Martin KH, Karginov AV, Parsons JT (2002) The association of ASAP1, an ADP ribosylation factor-GTPase activating protein, with focal adhesion kinase contributes to the process of focal adhesion assembly. Mol Biol Cell 13(6):2147鈥?156 CrossRef
  100. Onodera Y, Hashimoto S, Hashimoto A et al (2005) Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities. Embo J 24(5):963鈥?73 CrossRef
  101. Hashimoto S, Hirose M, Hashimoto A et al (2006) Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis. Proc Natl Acad Sci U S A 103(18):7036鈥?041 CrossRef
  102. Ehlers JP, Worley L, Onken MD, Harbour JW (2005) DDEF1 is located in an amplified region of chromosome 8q and is overexpressed in uveal melanoma. Clin Cancer Res 11(10):3609鈥?613 CrossRef
  103. Huang X, Godfrey TE, Gooding WE, McCarty KS Jr, Gollin SM (2006) Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45(11):1058鈥?069 CrossRef
  104. Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I (2000) Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157(2):369鈥?75
  105. Joberty G, Perlungher RR, Macara IG (1999) The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins. Mol Cell Biol 19(10):6585鈥?597
  106. Hirsch DS, Pirone DM, Burbelo PD (2001) A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes. J Biol Chem 276(2):875鈥?83 CrossRef
  107. Joberty G, Perlungher RR, Sheffield PJ et al (2001) Borg proteins control septin organization and are negatively regulated by Cdc42. Nat Cell Biol 3(10):861鈥?66 CrossRef
  108. Finger FP (2002) One ring to bind them. Septins and actin assembly. Dev Cell 3(6):761鈥?63 CrossRef
  109. Belbin TJ, Singh B, Smith RV et al (2005) Molecular profiling of tumor progression in head and neck cancer. Arch Otolaryngol Head Neck Surg 131(1):10鈥?8 CrossRef
  110. Glading A, Lauffenburger DA, Wells A (2002) Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol 12(1):46鈥?4 CrossRef
  111. Franco SJ, Huttenlocher A (2005) Regulating cell migration: calpains make the cut. J Cell Sci 118(Pt 17):3829鈥?838 CrossRef
  112. Franco S, Perrin B, Huttenlocher A (2004) Isoform specific function of calpain 2 in regulating membrane protrusion. Exp Cell Res 299(1):179鈥?87 CrossRef
  113. Franco SJ, Rodgers MA, Perrin BJ et al (2004) Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol 6(10):977鈥?83 CrossRef
  114. Kulkarni S, Saido TC, Suzuki K, Fox JE (1999) Calpain mediates integrin-induced signaling at a point upstream of Rho family members. J Biol Chem 274(30):21265鈥?1275 CrossRef
  115. Bialkowska K, Kulkarni S, Du X, Goll DE, Saido TC, Fox JE (2000) Evidence that beta3 integrin-induced Rac activation involves the calpain-dependent formation of integrin clusters that are distinct from the focal complexes and focal adhesions that form as Rac and RhoA become active. J Cell Biol 151(3):685鈥?96 CrossRef
  116. Wu M, Yu Z, Fan J, Caron A, Whiteway M, Shen SH (2006) Functional dissection of human protease mu-calpain in cell migration using RNAi. FEBS Lett 580(13):3246鈥?256 CrossRef
  117. Sawhney RS, Cookson MM, Omar Y, Hauser J, Brattain MG (2006) Integrin alpha2-mediated ERK and calpain activation play a critical role in cell adhesion and motility via focal adhesion kinase signaling: identification of a novel signaling pathway. J Biol Chem 281(13):8497鈥?510 CrossRef
  118. Reichrath J, Welter C, Mitschele T et al (2003) Different expression patterns of calpain isozymes 1 and 2 (CAPN1 and 2) in squamous cell carcinomas (SCC) and basal cell carcinomas (BCC) of human skin. J Pathol 199(4):509鈥?16 CrossRef
  119. Turhani D, Krapfenbauer K, Thurnher D, Langen H, Fountoulakis M (2006) Identification of differentially expressed, tumor-associated proteins in oral squamous cell carcinoma by proteomic analysis. Electrophoresis 27(7):1417鈥?423 CrossRef
  120. Ghosh M, Song X, Mouneimne G, Sidani M, Lawrence DS, Condeelis JS (2004) Cofilin promotes actin polymerization and defines the direction of cell motility. Science 304(5671):743鈥?46 CrossRef
  121. Yamaguchi H, Lorenz M, Kempiak S et al (2005) Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin. J Cell Biol 168(3):441鈥?52 CrossRef
  122. Huang TY, DerMardirossian C, Bokoch GM (2006) Cofilin phosphatases and regulation of actin dynamics. Curr Opin Cell Biol 18(1):26鈥?1 CrossRef
  123. Song X, Chen X, Yamaguchi H, Mouneimne G, Condeelis JS, Eddy RJ (2006) Initiation of cofilin activity in response to EGF is uncoupled from cofilin phosphorylation and dephosphorylation in carcinoma cells. J Cell Sci 119(Pt 14):2871鈥?881 CrossRef
  124. Mouneimne G, Soon L, DesMarais V et al (2004) Phospholipase C and cofilin are required for carcinoma cell directionality in response to EGF stimulation. J Cell Biol 166(5):697鈥?08 CrossRef
  125. Mangone FR, Brentani MM, Nonogaki S et al (2005) Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma. Int J Exp Pathol 86(4):205鈥?12 CrossRef
  126. Young MR, Colburn NH (2006) Fra-1 a target for cancer prevention or intervention. Gene 379:1鈥?1 CrossRef
  127. van Dam H, Castellazzi M (2001) Distinct roles of Jun : Fos and Jun : ATF dimers in oncogenesis. Oncogene 20(19):2453鈥?464 CrossRef
  128. Bergers G, Graninger P, Braselmann S, Wrighton C, Busslinger M (1995) Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol Cell Biol 15(7):3748鈥?758
  129. Belguise K, Kersual N, Galtier F, Chalbos D (2005) FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24(8):1434鈥?444 CrossRef
  130. Ramos-Nino ME, Scapoli L, Martinelli M, Land S, Mossman BT (2003) Microarray analysis and RNA silencing link fra-1 to cd44 and c-met expression in mesothelioma. Cancer Res 63(13):3539鈥?545
  131. Young MR, Nair R, Bucheimer N et al (2002) Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently. Mol Cell Biol 22(2):587鈥?98 CrossRef
  132. Casalino L, De Cesare D, Verde P (2003) Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 23(12):4401鈥?415 CrossRef
  133. Vial E, Sahai E, Marshall CJ (2003) ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. Cancer Cell 4(1):67鈥?9 CrossRef
  134. Kjoller L, Hall A (2001) Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin. J Cell Biol 152(6):1145鈥?157 CrossRef
  135. Shuster MI, Han L, Le Beau MM et al (2000) A consistent pattern of RIN1 rearrangements in oral squamous cell carcinoma cell lines supports a breakage-fusion-bridge cycle model for 11q13 amplification. Genes Chromosomes Cancer 28(2):153鈥?63 CrossRef
  136. Bliss JM, Venkatesh B, Colicelli J (2005) The RIN Family of Ras Effectors. Methods Enzymol 407:335鈥?44
  137. Hu H, Bliss JM, Wang Y, Colicelli J (2005) RIN1 is an ABL tyrosine kinase activator and a regulator of epithelial-cell adhesion and migration. Curr Biol 15(9):815鈥?23 CrossRef
  138. Takino T, Tamura M, Miyamori H et al (2003) Tyrosine phosphorylation of the CrkII adaptor protein modulates cell migration. J Cell Sci 116(Pt 15):3145鈥?155 CrossRef
  139. Klemke RL, Leng J, Molander R, Brooks PC, Vuori K, Cheresh DA (1998) CAS/Crk coupling serves as a 鈥渕olecular switch鈥?for induction of cell migration. J Cell Biol 140(4):961鈥?72 CrossRef
  140. Boyle SN, Michaud GA, Schweitzer B, Predki PF, Koleske AJ (2007) A critical role for cortactin phosphorylation by Abl-family kinases in PDGF-induced dorsal-wave formation. Curr Biol 17(5):445鈥?51 CrossRef
  141. Niwa R, Nagata-Ohashi K, Takeichi M, Mizuno K, Uemura T (2002) Control of actin reorganization by Slingshot, a family of phosphatases that dephosphorylate ADF/cofilin. Cell 108(2):233鈥?46 CrossRef
  142. Ohta Y, Kousaka K, Nagata-Ohashi K et al (2003) Differential activities, subcellular distribution and tissue expression patterns of three members of Slingshot family phosphatases that dephosphorylate cofilin. Genes Cells 8(10):811鈥?24 CrossRef
  143. Uetrecht AC, Bear JE (2006) Coronins: the return of the crown. Trends Cell Biol 16(8):421鈥?26 CrossRef
  144. de Hostos EL, Bradtke B, Lottspeich F, Guggenheim R, Gerisch G (1991) Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits. Embo J 10(13):4097鈥?104
  145. Gatfield J, Albrecht I, Zanolari B, Steinmetz MO, Pieters J (2005) Association of the leukocyte plasma membrane with the actin cytoskeleton through coiled coil-mediated trimeric coronin 1 molecules. Mol Biol Cell 16(6):2786鈥?798 CrossRef
  146. Humphries CL, Balcer HI, D鈥橝gostino JL et al (2002) Direct regulation of Arp2/3 complex activity and function by the actin binding protein coronin. J Cell Biol 159(6):993鈥?004 CrossRef
  147. Cai L, Holoweckyj N, Schaller MD, Bear JE (2005) Phosphorylation of coronin 1B by protein kinase C regulates interaction with Arp2/3 and cell motility. J Biol Chem 280(36):31913鈥?1923 CrossRef
  148. Cai L, Marshall TW, Uetrecht AC, Schafer DA, Bear JE (2007) Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. Cell 128(5):915鈥?29 CrossRef
  149. Schuuring E (1995) The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes鈥揳 review. Gene 159(1):83鈥?6 CrossRef
  150. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C (2000) EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6(8):3177鈥?182
  151. Rothschild BL, Shim AH, Ammer AG et al (2006) Cortactin overexpression regulates actin-related protein 2/3 complex activity, motility, and invasion in carcinomas with chromosome 11q13 amplification. Cancer Res 66(16):8017鈥?025 CrossRef
  152. Cosen-Binker LI, Kapus A (2006) Cortactin: the gray eminence of the cytoskeleton. Physiology (Bethesda) 21:352鈥?61
  153. Weaver AM, Karginov AV, Kinley AW et al (2001) Cortactin promotes and stabilizes Arp2/3-induced actin filament network formation. Curr Biol 11(5):370鈥?74 CrossRef
  154. Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, Weaver AM (2005) Cortactin promotes cell motility by enhancing lamellipodial persistence. Curr Biol 15(14):1276鈥?285 CrossRef
  155. Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC (2006) Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res 66(6):3034鈥?043 CrossRef
  156. Clark ES, Whigham AS, Yarbrough WG, Weaver AM (2007) Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia. Cancer Res 67(9):4227鈥?235 CrossRef
  157. Weed SA, Parsons JT (2001) Cortactin: coupling membrane dynamics to cortical actin assembly. Oncogene 20(44):6418鈥?434 CrossRef
  158. Bowden ET, Onikoyi E, Slack R et al (2006) Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells. Exp Cell Res 312(8):1240鈥?253 CrossRef
  159. Li Y, Tondravi M, Liu J et al (2001) Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 61(18):6906鈥?911
  160. Martinez-Quiles N, Ho HY, Kirschner MW, Ramesh N, Geha RS (2004) Erk/Src phosphorylation of cortactin acts as a switch on-switch off mechanism that controls its ability to activate N-WASP. Mol Cell Biol 24(12):5269鈥?280 CrossRef
  161. Boeckers TM, Bockmann J, Kreutz MR, Gundelfinger ED (2002) ProSAP/Shank proteins - a family of higher order organizing molecules of the postsynaptic density with an emerging role in human neurological disease. J Neurochem 81(5):903鈥?10 CrossRef
  162. Han W, Kim KH, Jo MJ et al (2006) Shank2 associates with and regulates Na+/H+ exchanger 3. J Biol Chem 281(3):1461鈥?469 CrossRef
  163. Freier K, Sticht C, Hofele C et al (2006) Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45(2):118鈥?25 CrossRef
  164. Du Y, Weed SA, Xiong WC, Marshall TD, Parsons JT (1998) Identification of a novel cortactin SH3 domain-binding protein and its localization to growth cones of cultured neurons. Mol Cell Biol 18(10):5838鈥?851
  165. Lim S, Sala C, Yoon J et al (2001) Sharpin, a novel postsynaptic density protein that directly interacts with the shank family of proteins. Mol Cell Neurosci 17(2):385鈥?97 CrossRef
  166. Okamoto PM, Gamby C, Wells D, Fallon J, Vallee RB (2001) Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton. J Biol Chem 276(51):48458鈥?8465
  167. Baldassarre M, Pompeo A, Beznoussenko G et al (2003) Dynamin participates in focal extracellular matrix degradation by invasive cells. Mol Biol Cell 14(3):1074鈥?084 CrossRef
  168. Kumar R, Gururaj AE, Barnes CJ (2006) p21-activated kinases in cancer. Nat Rev Cancer 6(6):459鈥?71 CrossRef
  169. Manser E, Leung T, Salihuddin H, Zhao ZS, Lim L (1994) A brain serine/threonine protein kinase activated by Cdc42 and Rac1. Nature 367(6458):40鈥?6 CrossRef
  170. Papakonstanti EA, Stournaras C (2002) Association of PI-3 kinase with PAK1 leads to actin phosphorylation and cytoskeletal reorganization. Mol Biol Cell 13(8):2946鈥?962 CrossRef
  171. Sells MA, Knaus UG, Bagrodia S, Ambrose DM, Bokoch GM, Chernoff J (1997) Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr Biol 7(3):202鈥?10 CrossRef
  172. Sells MA, Boyd JT, Chernoff J (1999) p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J Cell Biol 145(4):837鈥?49 CrossRef
  173. Edwards DC, Sanders LC, Bokoch GM, Gill GN (1999) Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1(5):253鈥?59 CrossRef
  174. Yoshioka K, Foletta V, Bernard O, Itoh K (2003) A role for LIM kinase in cancer invasion. Proc Natl Acad Sci USA 100(12):7247鈥?252 CrossRef
  175. Vadlamudi RK, Li F, Barnes CJ, Bagheri-Yarmand R, Kumar R (2004) p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate. EMBO Rep 5(2):154鈥?60 CrossRef
  176. Vadlamudi RK, Li F, Adam L et al (2002) Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol 4(9):681鈥?90 CrossRef
  177. Webb BA, Zhou S, Eves R, Shen L, Jia L, Mak AS (2006) Phosphorylation of cortactin by p21-activated kinase. Arch Biochem Biophys 456(2):183鈥?93 CrossRef
  178. Yang Z, Bagheri-Yarmand R, Wang RA et al (2004) The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells. Clin Cancer Res 10(2):658鈥?67 CrossRef
  
• 作者单位：Laura C. Kelley (1)
  Sohrab Shahab (2)
  Scott A. Weed (1)
  
  1. Department of Neuroscience and Anatomy, Program in Cancer Cell Biology, Mary Babb Randolph Cancer Center, West Virginia University, Morgantown, WV, 26506-9300, USA
  2. Department of Otolaryngology, West Virginia University, Morgantown, WV, 26506-9200, USA
  
• ISSN：1573-7276

文摘

Coordinated regulation of the actin cytoskeleton is central to cell motility, invasion and metastasis. Head and neck squamous cell carcinoma (HNSCC) is a highly invasive disease displaying frequent lymph node metastasis, compounding patient management. HNSCC progression is characterized by frequent amplification of chromosome segments 3q26-29, 8q23-24 and 11q13, events that are associated with poor patient outcome. The relative frequency of these amplification events and correlation with invasive disease raises the potential that these regions harbor actin regulatory genes important in facilitating reorganization of the actin cytoskeleton to promote tumor invasion. Identification of the actin cytoskeletal regulatory genes located within the 3q26-29, 8q23-24 and 11q13 amplicons will provide an important first step towards the comprehensive understanding of the molecular events that govern invasion and metastasis in HNSCC and other tumors containing these amplifications. We utilized Ensembl MartView to conduct a gene mining analysis within chromosome segments 3q26-29, 8q23-24 and 11q13 to identify known and predicted regulators of actin-based cell movement, tumor invasion and metastasis. All examined chromosomal regions contain genes known that regulate the actin cytoskeleton, with several (PI3-kinase alpha, focal adhesion kinase (FAK) and cortactin) known to promote invasion in HNSCC and other carcinomas. Additional genes known to regulate motility and invasion were also identified. Amplification of chromosome 3q26-29, 8q23-24 and 11q13 therefore results in known or predicted overexpression of several key mediators that can act alone or potentially act in concert to promote actin-based cell invasion in HNSCC and other cancer types.